have sent us. These do not necessarily have to be the final versions - we also accept drafts initially. Our team will read and analyze them and make an initial risk assessment.
The relevant information is summarized and then we present our summary to selected, first-class insurance companies. By first-class we mean those with an experienced underwriting team that are familiar with the world of the pharmaceutical industry, medical device manufacturers and contract researchers. They will work closely with us to assess the risks associated with the clinical trial and calculate the insurance premium. This will then result in an offer for the cover you require. Similarly, any necessary reinsurance is initiated by the primary insurer. All parties involved are obliged to treat information as strictly confidential. This is a completely normal process in the insurance industry, without which we would never be able to carry out our business.
We can, of course, set this down in writing in a mutual confidentiality agreement.
